Myofibrillar bound cyclic nucleotide phosphodiesterase in heart and skeletal muscle.
Worby
A
A
SmithKline Beecham Pharmaceuticals, Frythe, Welwyn, Herts.
Mensah
L M
LM
Murray
K J
KJ
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D015106:3',5'-Cyclic-GMP Phosphodiesterases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D000818:Animals; D002458:Cell Fractionation; D006168:Guinea Pigs; D007700:Kinetics; D020105:Milrinone; D009132:Muscles / Q000201:enzymology*; D009206:Myocardium / Q000201:enzymology*; D009210:Myofibrils / Q000201:enzymology* / Q000648:ultrastructure; D011724:Pyridazines / Q000494:pharmacology; D011728:Pyridones / Q000494:pharmacology; D011760:Pyrrolidinones / Q000494:pharmacology; D051381:Rats; D020889:Rolipram; D014970:Xanthines / Q000494:pharmacology
D011724:Pyridazines; D011728:Pyridones; D011760:Pyrrolidinones; D014970:Xanthines; C043898:denbufylline; C042527:imazodan; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D015106:3',5'-Cyclic-GMP Phosphodiesterases; D020105:Milrinone; D020889:Rolipram